U.S. stock futures are edging mostly higher as market participants focus on tech stocks and corporate earnings; Honeywell announces a split of its automation, aerospace, and advan ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against the other cheap quarterly dividend stocks. Growth stocks are typically seen as companies ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against Coatue’s other most important AI stocks. Artificial intelligence (AI) has fueled a major ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

Below is Validea's guru fundamental report for QUALCOMM INC (QCOM). Of the 22 guru strategies we follow, QCOM rates highest using our P/E/Growth Investor model based on the published strategy of ...

Eli Lilly shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue.

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...